Ameresco saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 69 to 79.
When To Sell Stocks To Lock In Profits And Minimize Losses
IBD's unique rating identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the best stocks tend to have an 80 or higher RS Rating in the early stages of their moves. See if Ameresco can continue to show renewed price strength and hit that benchmark.
Ameresco is not currently showing a potential buy point. See if the stock goes on to form a promising consolidation that could kick off a new climb.
The company posted 0% EPS growth last quarter. Sales increased 18%. Keep an eye out for the company's next round of numbers on or around Aug. 4.
The company holds the No. 20 rank among its peers in the Energy-Alternative/Other industry group. Bloom Energy, Enlight Renewable Energy and Centrus Energy are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
